Clinical Trials Browser

Phase 2 × Solid Tumors × Other solid neoplasm × Clear all

NCT04123366 2026-04-22

MK-7339-007

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT07415031 2026-04-08

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT04589845 2026-04-02

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Phase 2 Active not recruiting

920 enrolled 2 FDA

Other solid neoplasm

Solid Tumors

NCT06651593 2026-03-24

Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07032077 2026-03-20

A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07018622 2026-03-11

DAPA-ARMOR

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07417501 2026-02-18

Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT05419375 2026-02-03

Screening Study for Participants With Malignant Tumors

Phase 2 Completed

Other solid neoplasm

Solid Tumors

NCT07178938 2025-11-14

THERANOVA

Phase 2 Not yet recruiting

BreastOther solid neoplasm

Solid Tumors

NCT07128576 2025-09-04

Romiplostim N01 for the Treatment of Thrombocytopenia Associated With Radiotherapy-Combined Treatment Regimens in Patients With Solid Tumors

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT01197885 2025-06-13

Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer

Phase 2 Completed

Other solid neoplasm

Solid Tumors

NCT06926751 2025-04-15

Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06761417 2025-01-08

A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT03477175 2025-01-07

Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials

Phase 2 Completed

40 enrolled 13 charts

Other solid neoplasm

Solid Tumors

NCT06762327 2025-01-07

Ensartinib in the Treatment of ALK Positive or MET Exon 14 Skipping Anvanced Solid Tumors Excluded Lung Cancer

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06331598 2024-12-24

IMperator

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumors

NCT05522582 2024-10-26

Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT01190644 2023-11-29

Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Participants With Solid Tumors

Phase 2 Terminated

5 enrolled 11 charts

Other solid neoplasm

Solid Tumors

NCT02506517 2023-08-01

A Study of Afatinib in Patients With Advanced Cancer With Changes in the HER Gene

Phase 2 Completed

Other solid neoplasm

Solid Tumors

NCT02426892 2023-04-18

Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors

Phase 2 Completed

33 enrolled 14 charts

Other solid neoplasm

Solid Tumors

NCT03616834 2023-03-22

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

Phase 2 Completed

Other solid neoplasm

Solid Tumors

NCT02700308 2022-07-28

KYPHO-01

Phase 2 Terminated

Other solid neoplasm

Solid Tumors

NCT03264066 2021-05-11

A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors

Phase 2 Completed

87 enrolled 24 charts

Other solid neoplasm

Solid Tumors

NCT02451007 2019-11-19

Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors

Phase 2 Completed

39 enrolled 11 charts

Other solid neoplasm

Solid Tumors

NCT01634555 2019-02-26

A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI

Phase 2 Completed

29 enrolled 12 charts

Other solid neoplasm

Solid Tumors

NCT01624467 2016-07-25

A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors

Phase 2 Completed

75 enrolled 12 charts

Other solid neoplasm

Solid Tumors

NCT00360867 2015-10-15

An Open Label Treatment Extension Study of AMG 706

Phase 2 Terminated

Other solid neoplasm

Solid Tumors

NCT02120118 2015-06-09

Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumors

NCT01940601 2015-01-14

Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumors

NCT02045719 2014-01-27

cat´sclaw

Phase 2 Unknown

Other solid neoplasm

Solid Tumors

NCT00697437 2013-12-10

Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel

Phase 2 Completed

Other solid neoplasm

Solid Tumors

NCT00628732 2009-01-28

A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors

Phase 2 Completed

Other solid neoplasm

Solid Tumors

NCT00192777 2007-10-08

Concurrent Xeloda and Radiotherapy for Bone Metastases

Phase 2 Unknown

Other solid neoplasm

Solid Tumors